A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease (NCT07223502)
A Randomized, Parallel, Two Arm Study Comparing the Net Clinical Benefit of Finerenone Versus a Fixed Dose Combination of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and PRoteinuric ChrOnic KidNey Disease
🩺 Plain-English Summary (8th-Grade Level)
A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients with Hypertension and Chronic Kidney Disease.
Who can join: Review the eligibility criteria below.
Location: Sarfez Pharmaceuticals, Inc. — Vienna, Virginia
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Sarfez Pharmaceuticals, Inc. — Vienna, Virginia
📞 Contact the Study Coordinator
Phone: (877) 872-7339
Email: info@sarfez.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertension (HTN)
- Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension — Houston, Texas
- The BASIC-S Feasibility Study for Vascular Risk Reduction — London, Ontario
- Dual-Language B-MORE for Hypertension — Orlando, Florida
- Assessing the Feasibility of the "Heart Care Pairs" Intervention — Birmingham, Alabama
- IMPACT-HTN Study of Patients With Hypertension — Palo Alto, California
- Genetic Architecture of Natriuretic Peptides and Blood Pressure Response — Birmingham, Alabama
Explore by condition: All Hypertension (HTN) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.